...
首页> 外文期刊>BMC Microbiology >Characterization of a bacterial strain Lactobacillus paracasei LP10266 recovered from an endocarditis patient in Shandong, China
【24h】

Characterization of a bacterial strain Lactobacillus paracasei LP10266 recovered from an endocarditis patient in Shandong, China

机译:山东山东心内膜炎患者中患者的细菌菌株Lactobacillus paraca rp10266的表征

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Lactobacilli are often recognized as beneficial partners in human microbial environments. However, lactobacilli also cause diseases in human, e.g. infective endocarditis (IE), septicaemia, rheumatic vascular disease, and dental caries. Therefore, the identification of potential pathogenic traits associated with lactobacilli will facilitate the prevention and treatment of the diseases caused by lactobacilli. Herein, we investigated the genomic traits and pathogenic potential of a novel bacterial strain Lactobacillus paracasei LP10266 which has caused a case of IE. We isolated L. paracasei LP10266 from an IE patient’s blood to perform high-throughput sequencing and compared the genome of strain LP10266 with those of closely related lactobacilli to determine genes associated with its infectivity. We performed the antimicrobial susceptibility testing on strain LP10266. We assessed its virulence by mouse lethality and serum bactericidal assays as well as its serum complement- and platelet-activating ability. The biofilm formation and adherence of strain LP10266 were also studied. Phylogenetic analysis revealed that strain LP10266 was allied with L. casei and L. paracasei. Genomic studies revealed two spaCBA pilus clusters and one novel exopolysaccharides (EPS) cluster in strain LP10266, which was sensitive to ampicillin, penicillin, levofloxacin, and imipenem, but resistant to cefuroxime, cefazolin, cefotaxime, meropenem, and vancomycin. Strain LP10266 was nonfatal and sensitive to serum, capable of activating complement 3a and terminal complement complex C5b-9 (TCC). Strain LP10266 could not induce platelet aggregation but displayed a stronger biofilm formation ability and adherence to human vascular endothelial cells (HUVECs) compared to the standard control strain L. paracasei ATCC25302. The genome of a novel bacterial strain L. paracasei LP10266 was sequenced. Our results based on various types of assays consistently revealed that L. paracasei LP10266 was a potential pathogen to patients with a history of cardiac disease and inguinal hernia repair. Strain LP10266 showed strong biofilm formation ability and adherence, enhancing the awareness of L. paracasei infections.
机译:乳酸杆菌通常被认为是人类微生物环境中的有益伙伴。然而,乳酸杆菌也会引起人类的疾病,例如人类。感染性心内膜炎(即),败血症,风湿血管疾病和龋齿。因此,鉴定与乳杆菌相关的潜在致病性状将有助于预防和治疗由乳酸杆菌引起的疾病。在此,我们研究了一种新型细菌菌株乳酸杆菌LP10266的基因组性状和致病潜力,其引起了IE的情况。我们从IE患者的血液中分离L. paracasei LP10266,以进行高通量测序,并将菌株LP10266的基因组与密切相关的乳酸杆菌进行比较,以确定与其感染性相关的基因。我们在菌株LP10266上进行了抗微生物敏感性测试。我们通过小鼠致死性和血清杀菌试验以及其血清互补和血小板活化能力来评估其毒力。还研究了生物膜形成和菌株LP10266的粘附。系统发育分析表明,菌株LP10266与L.酪虫和L. parac酶缔结。基因组研究揭示了菌株LP10266中的两个Spacba菌落簇和一种新的潜水糖(EPS)簇,对氨苄西林,青霉素,左氧氟沙星和ImipeNem敏感,但耐毒细胞,Cefazolin,Cefotaxime,Meropenem和万古霉素。菌株LP10266对血清的敏感性和敏感性,能够激活补体3A和末端补体C5B-9(TCC)。菌株LP10266不能诱导血小板聚集,但与标准对照菌株L. paracasei ATCC25302相比,呈现出更强的生物膜形成能力和粘附对人血管内皮细胞(HUVECS)。测序新型细菌菌株L. paracasei Lp10266的基因组。我们的结果基于各种类型的测定始终揭示了L. paracasei LP10266是患有心脏病和腹股沟疝修复历史患者的潜在病原体。菌株LP10266显示出强烈的生物膜形成能力和粘附,增强了L. paracase感染的认识。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号